IDT Australia Ltd - Company Profile
Powered by 
All the data and insights you need on IDT Australia Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date IDT Australia Ltd Strategy Report
- Understand IDT Australia Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. It undertakes the process of manufacturing from initial drug development to clinical trials. The company provides a range of services including chemical, pharmacy, regulatory services, analytical chemistry, project management services, and clinical packaging for early phase clinical trials. IDT is headquartered in Boronia, Victoria, Australia.
Headquarters
Australia
Address
45 Wadhurst Dr, Boronia, Melbourne, Victoria, 3155
Website
en.idtaus.com.au
Telephone
61 3 98018888
No of Employees
156
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
IDT (ASX)
Revenue (2023)
$4.9M
-42%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
-632.6%
(2023 vs 2022)
Market Cap*
$21.8M
Net Profit Margin (2023)
XYZ
-1,164.1%
(2023 vs 2022)
* As of and is in US$
IDT Australia Ltd premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Active Pharmaceutical Ingredient | Clinical Packaging |
| Finished Dosage Forms | Contract Manufacturing Services |
| Chemical Services | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | IDT Australia Ltd | Australian Pharmaceutical Industries Ltd | GMP Pharmaceuticals Pty Ltd | Lipa Pharmaceuticals Ltd | Novotech Australia Pty Ltd |
|---|---|---|---|---|---|
| Headquarters | Australia | Australia | Australia | Australia | Australia |
| City | Melbourne | Melbourne | Sydney | Minto | Sydney |
| State/Province | Victoria | Victoria | New South Wales | New South Wales | New South Wales |
| No. of Employees | 156 | 5,105 | - | 380 | - |
| Entity Type | Public | Private | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mark Simari | Chairman | Executive Board | 2023 | - |
| Paul McDonald | Chief Executive Officer | Senior Management | 2023 | - |
| Vasantha Kumar Mahendran | Chief Financial Officer | Senior Management | 2022 | - |
| Priscilla Thiyageas | Director - Quality | Senior Management | - | - |
| Mark Licciardo | Secretary | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer